Your browser doesn't support javascript.
loading
New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim.
Ghidini, Michele; Hahne, Jens Claus; Trevisani, Francesco; Panni, Stefano; Ratti, Margherita; Toppo, Laura; Tomasello, Gianluca.
Afiliación
  • Ghidini M; Medical Department, Division of Oncology, ASST di Cremona, Ospedale di Cremona, Cremona, Italy.
  • Hahne JC; Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton, UK.
  • Trevisani F; Department of Urology, Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI, Milan, Italy.
  • Panni S; Medical Department, Division of Oncology, ASST di Cremona, Ospedale di Cremona, Cremona, Italy.
  • Ratti M; Medical Department, Division of Oncology, ASST di Cremona, Ospedale di Cremona, Cremona, Italy.
  • Toppo L; Medical Department, Division of Oncology, ASST di Cremona, Ospedale di Cremona, Cremona, Italy.
  • Tomasello G; Medical Department, Division of Oncology, ASST di Cremona, Ospedale di Cremona, Cremona, Italy.
Ther Clin Risk Manag ; 12: 1009-15, 2016.
Article en En | MEDLINE | ID: mdl-27445479

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ther Clin Risk Manag Año: 2016 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ther Clin Risk Manag Año: 2016 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Nueva Zelanda